Pertzye approved for pancreatic insufficiency.
Kate
K
Traynor
D017277:Drug Approval; D010188:Exocrine Pancreatic Insufficiency / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D020799:Pancrelipase / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D005765:Gastrointestinal Agents; D020799:Pancrelipase